Kennedy Elizabeth A, King Katherine Y, Baldridge Megan T
Division of Infectious Diseases, Department of Medicine, Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO, United States.
Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States.
Front Physiol. 2018 Oct 31;9:1534. doi: 10.3389/fphys.2018.01534. eCollection 2018.
As the intestinal microbiota has become better appreciated as necessary for maintenance of physiologic homeostasis and also as a modulator of disease processes, there has been a corresponding increase in manipulation of the microbiota in mouse models. While germ-free mouse models are generally considered to be the gold standard for studies of the microbiota, many investigators turn to antibiotics treatment models as a rapid, inexpensive, and accessible alternative. Here we describe and compare these two approaches, detailing advantages and disadvantages to both. Further, we detail what is known about the effects of antibiotics treatment on cell populations, cytokines, and organs, and clarify how this compares to germ-free models. Finally, we briefly describe recent findings regarding microbiota regulation of infectious diseases and other immunologic challenges by the microbiota, and highlight important future directions and considerations for the use of antibiotics treatment in manipulation of the microbiota.
随着肠道微生物群作为维持生理稳态的必要条件以及疾病进程的调节因子而得到更好的认识,在小鼠模型中对微生物群的操纵相应增加。虽然无菌小鼠模型通常被认为是微生物群研究的金标准,但许多研究人员转向抗生素治疗模型作为一种快速、廉价且易于获得的替代方法。在这里,我们描述并比较这两种方法,详细说明两者的优缺点。此外,我们详细阐述了抗生素治疗对细胞群体、细胞因子和器官的影响,并阐明了与无菌模型相比的情况。最后,我们简要描述了关于微生物群对传染病的调节以及微生物群面临的其他免疫挑战的最新发现,并强调了在操纵微生物群中使用抗生素治疗的重要未来方向和注意事项。